A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris

S

Sebacia

Status

Completed

Conditions

Facial Acne Vulgaris

Treatments

Device: Sebacia Microparticles

Study type

Interventional

Funder types

Industry

Identifiers

NCT02758041
SEB-0294CH, SEB-0400

Details and patient eligibility

About

This study is proposed to evaluate Sebacia Microparticle treatment in patients with facial inflammatory acne vulgaris.

Enrollment

85 patients

Sex

All

Ages

16 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female, 16-45 years of age.
  • Moderate to moderately-severe facial inflammatory acne vulgaris
  • Fitzpatrick skin phototype I-III

Exclusion criteria

  • Pregnant, lactating, nursing or planning to become pregnant
  • Tattoo in the treatment area
  • Active skin disease, excessive scarring or excess facial hair in the treatment area
  • Certain current or recent acne treatments
  • Recent light treatments including Intense Pulsed Light or other lasers, microdermabrasion or chemical peels in the treatment area
  • Contraindicated for laser treatment, or is unable or unwilling to avoid excessive sun exposure or tanning bed use
  • Known allergy to gold

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

85 participants in 1 patient group

Sebacia Microparticles
Experimental group
Treatment:
Device: Sebacia Microparticles

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems